CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GMAB

Acasunlimab

Phase 3
Genmab A/S (GMAB)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
GMABPhase 3

Acasunlimab Phase 3 Est. Readout

Acasunlimab
Q3 2027~Q
CT.gov
00%
Competitive Landscape

1 competitor in Cutaneous Melanoma

View Full Landscape
Drug Information

Target Indication

Cutaneous Melanoma

Clinical Trial

NCT06984328

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.